Impacto en la calidad de vida de los adolescentes con diabetes mellitus tipo 1

Fuentes, Francisca Lizama; Rojas, Sergio Ormeño; Liberona, Francisca Mourguiart; Cammell, Joaquin Fuentes; López-Alegría, Fanny

doi:10.32641/rchped.v91i6.2457

Cited by 3 publications

(1 citation statement)

References 34 publications

(136 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared with adults over 40 years of age, people with diabetes between 20 and 40 years old tend to be less aware of the severity of this disease. So, it leads to poor management, generating risk factors related to DM (Fuentesa et al, 2020;Machado Romero et al, 2010), in such a way that the productive life of the person with DM can be shortened between 5 to 10 years for adults and between 16 years for young people (Alshayban and Joseph, 2020;Grudziąż-Sękowska et al, 2021).…”

Section: Introductionmentioning

confidence: 99%

Quality of life in diabetics who attend the outpatient clinic of a hospital in North Lima

Perez-Siguas¹,

Matta-Solís²,

Matta-Solis³

2023

Int. j. adv. appl. sci.

View full text Add to dashboard Cite

Diabetes mellitus is one of the main problems worldwide, where risk factors in diabetic patients generate changes in their quality of life, putting their health at risk by altering the physical and emotional capacity of the person who suffers from it. The research objective is to determine the quality of life of diabetics who attend the outpatient clinic of a Hospital in North Lima. In the results, of the 132 participating patients, 18 (13.6%) diabetic patients have a low quality of life, 73 (55.3%) have a medium quality of life, and 41 (31.1%) have a high quality of life. It is concluded that diabetic patients should be guided and educated in relation to their self-care allows for generating changes at the behavioral level, and thus guarantees that they have a full and controlled quality of life.

show abstract

Section: Introductionmentioning

confidence: 99%

Quality of life in diabetics who attend the outpatient clinic of a hospital in North Lima

Perez-Siguas¹,

Matta-Solís²,

Matta-Solis³

2023

Int. j. adv. appl. sci.

View full text Add to dashboard Cite

show abstract

Glycemic control parameters in children with type 1 diabetes treated with fast-acting insulin aspart domestic biosimilar by continuous subcutaneous infusion

Platonov,

Dubinina,

Patrakeeva

et al. 2023

Medicinskij sovet

View full text Add to dashboard Cite

Introduction. Type 1 diabetes (T1D) is a chronic autoimmune disease requiring constant insulin therapy under regular continuous monitoring of glycemic parameters. The use of domestic insulin bioanalogues in CSII therapy is currently not sufficiently covered in the literature.Aim. To evaluate glycemic control parameters in children with T1D treated with the domestic fast-acting insulin aspart biosimilar by CSII.Materials and methods. Retrospective study was carried out on the basis of K.A. Raukhfus center St. Petersburg State Medical and Biomedical Center VMT. Fifty-five children with T1D aged 6 to 17 years (mean age 12 ± 4) were examined, including 29 boys (52.7%, mean age 11 ± 3 years) and 26 girls (47.3%, mean age 13 ± 4 years). Insulin therapy was carried out by systems of CSII Glycemic parameters were monitored by continuous and flash glycemic monitoring systems. The center visits frequency was once a month.Results. During dynamic follow-up after 3 and 6 months, children showed statistically significant (p < 0.05) improvement in glycemic control parameters–decrease in HbA1c level from 8.0 ± 1.8% to 7, 1 ± 1.2% and 6.8 ± 0.6%, increase in TIR from 60.4 ± 20.6% to 71.5 ± 13.0% and 75.9 ± 9.4%, decrease in TAR from 31.1 ± 22.1% to 23.0 ± 12.8% and 20.3 ± 9.3%, decrease in TBR from 9.1 ± 8.2% to 5.8 ± 4.3% and 4.1 ± 1.8%, and decrease in CV from 40.0 ± 9.1% to 33.7 ± 6.7% and 32.5 ± 5.6%.Discussion. The use of domestic biosimilar insulin aspart in insulin pumps iis associated with significant improvement in glycemic control in children and adolescents with T1D. Dynamic observation together with therapeutic education contribute to the maintenance of the achieved parameters at a high level.Conclusions. Therapy with the domestic fast-acting insulin aspart biosimilar by CSII allows achieving target glycemic control in children with T1D.

show abstract

Diet and Glycemic Index in Children with Type 1 Diabetes

et al. 2023

View full text Add to dashboard Cite

In children with type 1 diabetes, a healthy lifestyle is important to control postprandial glycemia and to avoid hyperglycemic peaks that worsen the inflammatory state of vessels and tissues. Glycemic index and glycemic load are two important indexes which assess the quality and quantity of foods consumed during meals. The main macronutrients of the diet have a different effect on postprandial blood glucose levels, so it is important that diabetic children consume foods which determine a slower and steadier glycemic peak. In this review, we present the results of the most recent studies carried out in the pediatric population with T1D, whose aim was to analyze the effects of low-glycemic-index foods on glycemic control. The results are promising and demonstrate that diets promoting low-glycemic-index foods guarantee a greater glycemic stability with a reduction in postprandial hyperglycemic peaks. However, one of the main limitations is represented by the poor adherence of children to a healthy diet. In order to obtain satisfactory results, a possibility might be to ensure a balanced intake of low-, moderate- and high-glycemic-index foods, preferring those with a low glycemic index and limiting the consumption of the high- and moderate-glycemic-index types.

show abstract

Impacto en la calidad de vida de los adolescentes con diabetes mellitus tipo 1

Cited by 3 publications

References 34 publications

Quality of life in diabetics who attend the outpatient clinic of a hospital in North Lima

Quality of life in diabetics who attend the outpatient clinic of a hospital in North Lima

Glycemic control parameters in children with type 1 diabetes treated with fast-acting insulin aspart domestic biosimilar by continuous subcutaneous infusion

Diet and Glycemic Index in Children with Type 1 Diabetes

Contact Info

Product

Resources

About